Aia Group LTD Regeneron Pharmaceuticals, Inc. Transaction History

Aia Group LTD

$3.67 Billion
Q3 2024

A detailed history of Aia Group LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Aia Group LTD holds 10,641 shares of REGN stock, worth $7.87 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

10,641

Previous 10,020 6.2%

Holding current value

$7.87 Million

Previous $10.5 Million 6.22%

% of portfolio

0.3%

Previous 0.32%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$1024.09 - $1201.76 $635,959 - $746,292	621 Added 6.2%	10,641 $11.2 Million
Q2 2024 Jul 31, 2024	BUY	$883.2 - $1071.19 $2.77 Million - $3.35 Million	3,132 Added 45.47%	10,020 $10.5 Million
Q1 2024 May 06, 2024	BUY	$902.69 - $993.35 $1.96 Million - $2.15 Million	2,166 Added 45.87%	6,888 $6.63 Million
Q4 2023 Jan 31, 2024	BUY	$775.18 - $881.7 $437,976 - $498,160	565 Added 13.59%	4,722 $4.15 Million
Q3 2023 Nov 01, 2023	SELL	$692.45 - $844.37 $383,617 - $467,780	-554 Reduced 11.76%	4,157 $3.42 Million
Q2 2023 Jul 28, 2023	BUY	$700.03 - $830.35 $753,932 - $894,286	1,077 Added 29.64%	4,711 $3.39 Million
Q1 2023 Apr 28, 2023	SELL	$680.49 - $826.97 $1.58 Million - $1.92 Million	-2,324 Reduced 39.01%	3,634 $2.99 Million
Q4 2022 Jan 31, 2023	SELL	$705.89 - $766.39 $509,652 - $553,333	-722 Reduced 10.81%	5,958 $4.3 Million
Q3 2022 Nov 04, 2022	BUY	$573.97 - $724.32 $918,925 - $1.16 Million	1,601 Added 31.52%	6,680 $4.6 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $1.01 Million - $1.36 Million	1,845 Added 57.05%	5,079 $3 Million
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $856,377 - $1.01 Million	1,439 Added 80.17%	3,234 $2.26 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $378,262 - $466,995	696 Added 63.33%	1,795 $1.13 Million
Q3 2021 Nov 05, 2021	BUY	$574.03 - $680.96 $221,001 - $262,169	385 Added 53.92%	1,099 $665,000
Q2 2021 Aug 03, 2021	SELL	$472.8 - $558.54 $380,131 - $449,066	-804 Reduced 52.96%	714 $418,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $131,785 - $161,719	295 Added 24.12%	1,518 $718,000
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $584,960 - $743,559	1,223 New	1,223 $601,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Account